title: Update on HIV-associated neurocognitive disorders.
abstract: Neurocognitive disorders are a feared complication of HIV infection, especially in the post-antiretroviral era as patients are living longer. These disorders are challenging in terms of diagnosis and treatment. The clinical syndrome has evolved, driven in part by comorbidities such as aging, drug abuse, psychiatric illnesses, and a metabolic syndrome associated with the use of antiretroviral drugs. Additionally some individuals may develop a fulminant immune reconstitution syndrome. Hence, treatment of these patients needs to be individualized. The focus of research in the HIV field has recently switched towards elimination of the HIV reservoir as a means of combating long-term HIV complications. However, these approaches may be suitable for limited populations and might not be applicable once the HIV reservoir has been established in the brain. Further, all clinical trials using neuroprotective or anti-inflammatory drugs for treatment of HIV-associated neurocognitive disorders have been unsuccessful. Hence, neurological complications of HIV infection are the biggest challenge facing HIV researchers, and there is a critical need to develop new diagnostics and approaches for treatment of these disorders.
authors: Section of Infections of the Nervous System, National Institute of Neurological Diseases and Stroke, National Institutes of Health, Bethesda, MD 20892, USA. tariq.alfahad@nih.gov
authors: Tariq B
authors: TB
authors: Alfahad
authors: Avindra
authors: A
authors: Nath
mesh_terms: D003072:Cognition Disorders / Q000209:etiology* / Q000821:virology*; D015658:HIV Infections / Q000150:complications*; D006801:Humans; D009422:Nervous System Diseases / Q000175:diagnosis / Q000209:etiology / Q000821:virology; D012307:Risk Factors; D009626:Terminology as Topic
references: Nature. 1990 Jan 4;343(6253):85-9
references: 2296295
references: Neurology. 1993 Nov;43(11):2245-52
references: 8232937
references: Antiviral Res. 2002 Aug;55(2):209-25
references: 12103427
references: PLoS One. 2008 Jun 25;3(6):e2516
references: 18575590
references: J Clin Exp Neuropsychol. 2006 May;28(4):536-48
references: 16676475
references: PLoS One. 2012;7(8):e43950
references: 22952817
references: J Neurosci. 2003 Sep 10;23(23):8417-22
references: 12968004
references: J Neuroimmune Pharmacol. 2009 Jun;4(2):190-9
references: 19288297
references: AIDS. 2006 Aug 1;20(12):1591-5
references: 16868439
references: J Neuroinflammation. 2011 Nov 30;8:167
references: 22129063
references: Neurology. 2002 Nov 26;59(10):1563-7
references: 12451198
references: J Clin Virol. 2010 Dec;49(4):231-8
references: 20833583
references: J Neurovirol. 2005 Jul;11(3):265-73
references: 16036806
references: Neurology. 2002 Dec 24;59(12):1944-50
references: 12499488
references: AIDS. 2011 Mar 13;25(5):577-80
references: 21160414
references: Neurology. 2012 Feb 14;78(7):485-92
references: 22330412
references: J Neurovirol. 2007 Jun;13(3):203-9
references: 17613710
references: J Neurosci. 2008 Nov 19;28(47):12190-8
references: 19020013
references: J Neurovirol. 2011 Feb;17(1):3-16
references: 21174240
references: Biomaterials. 2008 Nov;29(33):4429-38
references: 18760470
references: J Acquir Immune Defic Syndr. 2006 Dec 1;43(4):405-10
references: 17099311
references: PLoS One. 2010 Nov 15;5(11):e15533
references: 21125014
references: AIDS. 2009 Jul 17;23(11):1359-66
references: 19424052
references: J Virol. 1997 Apr;71(4):2928-33
references: 9060651
references: Science. 2011 May 13;332(6031):786
references: 21566174
references: Neurology. 2007 Oct 30;69(18):1789-99
references: 17914061
references: Antimicrob Agents Chemother. 2010 Dec;54(12):5156-60
references: 20876368
references: Proc Natl Acad Sci U S A. 2013 Aug 13;110(33):13588-93
references: 23898208
references: Nanomedicine (Lond). 2009 Jul;4(5):557-74
references: 19572821
references: Curr Opin Neurol. 2011 Jun;24(3):284-90
references: 21499099
references: Clin Med (Lond). 2011 Dec;11(6):571-5
references: 22268312
references: Top HIV Med. 2010 Apr-May;18(2):45-55
references: 20516524
references: J Neuroimmunol. 2004 Dec;157(1-2):185-92
references: 15579296
references: Proc Natl Acad Sci U S A. 2002 Oct 15;99(21):13795-800
references: 12374865
references: FASEB J. 2006 Jun;20(8):1209-11
references: 16636104
references: J Neurovirol. 2011 Feb;17(1):82-91
references: 21165790
references: J Infect Dis. 2011 Dec 15;204(12):1936-45
references: 22021620
references: AIDS Res Hum Retroviruses. 2001 Mar 20;17(5):377-83
references: 11282006
references: Adv Drug Deliv Rev. 1999 Oct 18;39(1-3):5-31
references: 10837765
references: Proc Natl Acad Sci U S A. 2006 Oct 10;103(41):15160-5
references: 17015824
references: PLoS Pathog. 2007 Apr;3(4):e46
references: 17411338
references: AIDS Res Hum Retroviruses. 2010 Apr;26(4):495-500
references: 20377428
references: Nat Biotechnol. 2010 Aug;28(8):839-47
references: 20601939
references: Retrovirology. 2012 Mar 15;9:20
references: 22420378
references: J Acquir Immune Defic Syndr. 2013 Feb 1;62(2):190-6
references: 23187938
references: J Neuroimmunol. 2004 Dec;157(1-2):197-202
references: 15579298
references: J Neurol Neurosurg Psychiatry. 1998 Jul;65(1):29-33
references: 9667557
references: BMJ. 2006 Jun 3;332(7553):1289
references: 16740537
references: AIDS. 2005 Jan 28;19(2):127-35
references: 15668537
references: Lancet. 2010 Mar 20;375(9719):1014-28
references: 20189638
references: Science. 2001 Aug 24;293(5534):1503-6
references: 11520990
references: AIDS. 2004 Jan 1;18 Suppl 1:S27-34
references: 15075495
references: Infect Genet Evol. 2011 Jan;11(1):31-7
references: 21055482
references: J Infect Dis. 2002 Dec 1;186 Suppl 2:S193-8
references: 12424697
references: J Neurovirol. 2010 May;16(3):230-41
references: 20367240
references: Neurology. 2009 Oct 20;73(16):1292-9
references: 19841381
references: Lancet Neurol. 2005 Sep;4(9):543-55
references: 16109361
references: Ann Neurol. 2004 Dec;56(6):873-7
references: 15562411
references: Neurology. 2004 Sep 14;63(5):822-7
references: 15365130
references: CNS Drugs. 2012 Feb 1;26(2):123-34
references: 22201342
references: J Med Life. 2011 Nov 14;4(4):432-9
references: 22514580
references: J Neurovirol. 2011 Feb;17(1):70-81
references: 21165788
references: Nat Rev Neurosci. 2007 Jan;8(1):33-44
references: 17180161
references: Proc Natl Acad Sci U S A. 2008 Mar 11;105(10):3879-84
references: 18332425